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Abstract 
For low dose CT lung cancer screening to be effective in curbing disease mortality, efforts are 
needed to overcome barriers to awareness and facilitate uptake of the current evidence-based 
screening guidelines. A sequential mixed-methods approach was employed to design a screening 
campaign utilizing messages developed from community focus groups, followed by 
implementation of the outreach campaign intervention in two high-risk Kentucky regions. This 
study reports on rates of awareness and screening in intervention regions, as compared to a 
control region. 
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1. Introduction 
 Lung cancer remains the leading cause of cancer death in the United States,1 accounting 
for about 1 in 4 cancer deaths.2 Early detection of the disease is notoriously poor, with only 16% 
of lung cancers diagnosed at a localized stage. The 5-year survival rate is 55% with early 
detection; however, this rate is cut in half (27%) if detected after regional spread.2 The potential 
for change in these statistics will be of special interest in the coming years, given the national 
coverage decision on Feb. 5, 2015, by the Centers for Medicare and Medicaid Services (CMS) 
for low dose computed tomography (LDCT) lung cancer screening for eligible Medicare 
beneficiaries.3 The CMS decision followed evidence from the National Lung Screening trial 
(NLST) that LDCT reduced lung cancer mortality by 20% compared to standard chest x-ray 
among adults with at least a 30 pack-year smoking history who were current smokers or had quit 
within 15 years.4 Review of the few existing studies on cost analytics, calculated as savings from 
a shift toward earlier stages at diagnosis relative to increased Medicare expenditures for 
screenings, also describe favorable results.5 
 Along with interventions to curb high rates of smoking, few states stand to benefit more 
from LDCT screening efforts than Kentucky. Compared to national averages for age-adjusted 
lung cancer incidence and mortality (63.7 and 47.2 per 100,000, respectively), Kentucky’s rates 
of 97.5 and 70.9 per 100,000, respectively, are the highest in the nation.6 The impact of the 
recommendation itself, however, is likely to be minimal unless efforts are made to overcome 
implementation delays and barriers to awareness and uptake of evidence-based screening 
guidelines.7 Early studies on implementation of LDCT screening show that patients are not 
aware of the recommendation8 and have limited knowledge of what a screening might entail;9 
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primary care providers also have shown limited understanding of the guidelines or the evidence 
for LDCT effectiveness.10,11 
 One of the CMS requirements when ordering a chest LDCT for lung cancer screening is 
documentation that a shared decision-making process was conducted and recorded in the medical 
record.3 This process is important, given that a primary concern for roll-out of LDCT screening 
is the risk associated with a false-positive result, 12,13 for which the implications (e.g., follow-up 
testing with the potential for more invasive biopsies and additional radiation) need to be properly 
identified and discussed with the patient. The requirement for shared decision-making is meant 
to assure that the potential risks, benefits, limitations, and uncertainties associated with LDCT 
screening are conveyed to the patient and that the patient has an opportunity to ask questions 
before a LDCT is ordered. Effectiveness of these sessions may be limited, however, given 
concern among providers that a lack of patient knowledge about LDCT presents a major barrier 
to LDCT screening.10 There is a clear need to address this knowledge gap as part of the larger 
effort to facilitate mutual respect and effective communication processes that are known to 
enhance the shared decision making process.14 
 Our team assessed whether a population approach to increasing awareness of the new 
guidelines might be effective in addressing the expectedly slow uptake of the screening initiative. 
To this end, we developed a community awareness campaign about the importance of lung 
cancer screening that would be especially sensitive to the unique cultural attitudes and 
perspectives in the high-need area of Eastern Kentucky. Our community-engaged approach 
utilized focus groups of local individuals who met criteria to be considered high-risk for lung 
cancer. Focus groups were gathered to elicit their opinions about lung cancer, lung cancer 
screening, and perceived salient and trusted messages about screening. Here we report on the 
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effectiveness of the resulting campaign, known as the Terminate Lung Cancer (TLC) program, 
based on community awareness of screening and rates of LDCT orders across two targeted 
Eastern Kentucky regions. Prior research describes development of our campaign materials and 
highlights our community-engaged approach as informed by our focus group efforts.9 We 
hypothesized that if our TLC program had met its goal of motivating patients to approach their 
health providers about their options for LDCT, there would be an increase in order rates for 
LDCT as compared to a control region where the campaign had not been implemented. 
2. Methods 
2.1. Targeted population regions.  
 We targeted three Eastern Kentucky regions located in and around the counties with the 
residing cities of Morehead, Hazard, and Pikeville, KY (Figure 1). Each of these areas is 
burdened with significant health disparities, and is characterized by significant behavioral, 
educational, and economic disparities (see Table 1). 
2.2. Mixed methods approach.  
 A sequential mixed-methods approach was implemented with focus group sessions 
conducted in October 2014, followed by implementation of the community outreach intervention 
in two intervention regions (Morehead and Hazard regions). The Pikeville region did not receive 
the marketing intervention and served as a control region for assessment of LDCT rates. All 
study procedures were approved by the University of Kentucky Institutional Review Board. 
 2.2.1. Focus groups and focus group findings. 
 Two focus groups were conducted in each region (six in total) in October 2014. 
Community health workers (CHWs) from Kentucky Homeplace (a health service organization 
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with a long collaborative history of supporting high-risk populations) recruited individuals from 
their local communities using established client files. Identified were men and women 55-77 
years of age with at least 30 pack-years of smoking: either former smokers (quit in last 15 years), 
or current smokers. These criteria match those for lung cancer screening. A total of fifty-four 
individuals (61.1% female; >55 pack year history) participated.  
 All sessions were recorded and transcribed for independent content analysis, with results 
described in a previous publication.9 Among the findings from these deliberative sessions was a 
list of themes that were identified for their potential effectiveness; these included messages about 
survivorship, family, and prolonged life. There was strong consensus among participants of the 
importance of testimony, such as seeing a picture of someone who had survived lung cancer after 
screening. With regard to the various venues and channels that might be used to disseminate 
information about lung cancer screening, this largely older and rural audience showed heavy 
reliance on information gained from their health providers, as well as family and friends. 
Recommendations also included: Flyers or information in doctor offices/waiting rooms and 
during annual exams; making LDCT screening information available in internet searches and in 
health websites; placing flyers in grocery stores and by direct mail; and traditional advertising 
using television, newspaper, and radio advertisements. 
 2.2.2. Development of lung cancer screening campaign: Campaign elements. 
 The media, venues, and methods of the campaign were informed by the outcomes of the 
focus group data described above. We developed messaging and images for postcard mailings 
and newspaper ads that included a TLC website address (See Figure 2). The TLC campaign did 
not include any television advertisements due to cost limitations. As described in our previous 
publication9, two members from each focus group were asked to serve on an advisory board that 
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participated in the development of the campaign elements, including final approval of all venues 
and materials used. Their function was to provide input and direction to ensure that perspectives 
of the targeted population, as derived from the focus groups in which they participated, were 
fully vetted and reflected in the messages and outcomes produced.  The final materials (see 
Figure 2) were selected to portray the common message of hope and survival, as this was an 
overriding theme discussed during the focus groups. 
 2.2.3. Campaign dissemination (intervention). 
 With importance given to information provided by a family doctor or specialty provider, 
we mailed 54,600 postcards equally within the intervention regions to 64 locations that included 
primary care, community health providers, county public health departments, and agricultural 
extension offices (AEOs). The University of Kentucky was founded as a land grant institution 
and has an enduring history of working with AEOs to engage rural populations for health 
education. A national framework developed by the Extension Committee on Organization & 
Policy of the Association of Public and Land-grant Universities has linked drivers utilizing 
AEOs and community-based health resources.15   
Along with the postcards, we enclosed information specific to providers on the LDCT 
guidelines, and a crosswalk comparison of the CMS coverage and the United States Preventive 
Services Task Force recommendations. We developed a website (www.terminatelungcancer.org) 
with links and resources for community members and providers, and sent a second letter to the 
same providers marketing the website. We held a physician roundtable event to provide an 
overview of our project and the LDCT screening guidelines in the Morehead region, which was 
attended by 26 physicians. A Hazard region roundtable was unfortunately canceled due to an 
insufficient number of registered participants. 
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 For broader community coverage, we purchased ads using the same design as the 
postcards that ran every 2 weeks in 17 community newspapers (9 in the Morehead region and 8 
in the Hazard region). For radio coverage, we ran ads on the local public radio station in the 
Morehead region twice daily for 6-months. Likewise in the Hazard region, we worked with 2 
local radio stations to run our spot one or more times per day. The radio ads message is shown in 
Figure 2. 
2.3. Outcome measures 
 2.3.1. Exposure and Behaviors Survey. 
 In order to assess reach of the campaign and community access to our dissemination 
efforts, we analyzed results from a telephone survey that was administered by three CHWs from 
each region. Call lists were generated from Kentucky Homeplace using their established client 
files to include members meeting the screening criteria described above, excluding any 
individuals who had participated in any of the prior six focus groups sessions. In their telephone 
call, respondents were asked if they had seen or heard any advertising, or other exposure, 
concerning lung cancer screening. If a respondent answered yes, they were asked where the ad 
was seen and/or heard, and if the exposure influenced them toward any specific considerations or 
to take action toward screening or smoking cessation. 
 2.3.2. LDCT uptake. 
 Three hospital systems (each non-affiliated with each other or with an academic center) 
partnered with the study. Each hospital is located in one of the 3 study regions, and each serves 
as the largest system with LDCT capacity for their respective region. To assess effectiveness of 
the campaign, we analyzed the monthly totals of chest LDCTs (CPT 71250) performed for any 
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ICD-9 code and those for an associated ICD code V76.0 (Special screening for malignant 
neoplasms of the respiratory organs) or V15.82 (Personal history to tobacco use, current/former 
ages 55-80 years) for the prior 12-months from each regional imaging center. These data were 
requested at baseline (end of 2014) and, again, post-intervention (end of 2015). 
 To monitor for external marketing activity by regional systems, specifically by hospital 
centers that offer LDCT, our team called and sent emails attempting to reach each hospital’s 
director of marketing, radiology or medical imaging center, and/or supervisor for oncology 
services. Feedback from this assessment was used to qualitatively interpret comparative analyses 
of campaign effectiveness. 
2.4. Statistical approach. 
 Survey results were assessed using descriptive and bivariate analyses. Counts and 
frequencies were calculated and chi-square analysis was performed to assess for statistical 
differences between the three studied regions. Statistical significance was achieved based on a p-
value <0.05 using SPSS version 21.0 software. 
 2.4.1. LDCT– Statistical process control. 
 We used statistical process control with our primary process measure of LDCTs for each 
region (calculated as number of LDCTs performed per population 100,000) displayed on control 
(c-) charts. This methodology assesses whether a process is stable (with variation only coming 
from sources that would be usual or common to the process), and we used established rules for 
differentiating special versus common cause variation for each c-chart.16-18 We plotted TLC 
campaign elements on the c-charts to assess for any temporal trends that may have arisen. Upper 
and lower control limits (UCL and LCL, respectively) were used to determine if special cause 
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variation (points on the timeline that exceed estimates of expected variability) achieved statistical 
significance. UCL and LCL for c-control charts are based on count data that are assumed to 
follow a Poisson distribution and based on the central limit theorem.19  Standard deviations are 
calculated as the square root of the mean central line defined as the sum of events (i.e., LDCTs) 
divided by the number of subgroups (i.e., number of time points). The upper and lower control 
limits are then calculated as the mean central line +/- 3 multiplied by the square root of the mean 
central line. 
3. Results 
 3.1. Study population regions 
While the Eastern Kentucky region is very homogenous, the region drastically differs in 
several measures when compared to non-Appalachia Kentucky and the rest of the US.  Low 
education and income levels, as presented in Table 1, are lower in the study regions when 
compared to Kentucky and the US. In addition, smoking rates are almost doubled when 
compared to the US and approximately 5% higher than the state average. Similar 
disproportionate patterns are observed for premature death and cancer death rates. 
 3.2. Exposure and Behaviors Survey results.  
 CHWs attempted to reach at least 50 screening-eligible individuals in each of the three 
regions. A total of 145 surveys were completed in all regions combined. Seventy-three (50.3%) 
answered “Yes” to the question of whether they had “seen or heard ads, messages, or postcards 
about lung cancer screening in doctor offices, local newspapers, or on the radio in the last 4-6 
months.” When the 73 individuals were asked if this exposure had led to any consideration 
and/or action, a total of 61 individuals (83.6%) reported a positive response for at least one 
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consideration or action taken, with a total of 100 considerations or behaviors reported. Results of 
this survey, including reports of exposure to the different campaign elements (described next), 
are shown in Table 2. 
 Comparison of individuals reporting that they had seen or heard about lung cancer 
screening in the last 4-6 months did not reveal any significant difference in overall exposure 
across the three regions (p=0.13). There were significant differences in the type of activity to 
which regions were exposed. Our two intervention regions both reported high rates of radio ad 
exposure compared to the Pikeville (Control) region (p=0.02). The Morehead region had the 
highest percentage reporting exposure to postcards in doctor offices and newspaper ads (p=0.01), 
with lower rates in the Hazard and Pikeville regions. A large percentage of respondents in the 
Pikeville (Control) region stated that they had seen television ads about lung cancer screening 
(not part of our campaign), which was significantly more than was found amongst those 
surveyed in the intervention regions (p<.001). 
 3.3. LDCT results. 
 As shown on the c-charts for each region, there was a significant uptake (exceeding the 
upper control limit) of LDCTs in the two intervention regions (Figure 3a), while no statistical 
significance was achieved in the Control region (Figure 3b). Moreover, the increasing trend in 
uptake of LDCTs was noted to occur after incremental elements of the TLC campaign were 
implemented. The Morehead region more than doubled the number of LDCTs per 100,000 
population from the beginning of 2015 and the Hazard region went from 0 to over 10 LDCTs per 
month per 100,000 population. The Pikeville (Control) region began with a baseline of 0 to 4 
LDCTs per month per 100,000 population, and failed to reach the upper control limit, peaking at 
little over 6 LDCTs per month per 100,000 population. 
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4. Discussion 
 4.1. Summary of results in context of literature. 
Translating recommendations and guidelines into practice is a lengthy process, taking an 
estimated 17 years to proceed from initial discovery to clinical implementation.20 The U.S. health 
care system heavily relies on published reports and continuing education to disseminate new 
guidelines, with the expectation that implementation will occur shortly thereafter ‒ a passive 
practice that has not proven effective.21,22 Our study assesses the impact of directly disseminating 
knowledge and information to communities in Eastern Kentucky. The messaging and awareness 
campaign sought to encourage high-risk individuals to speak with their health care provider 
about whether lung cancer screening was appropriate for them. Through our population-level 
comparative analyses, we demonstrated significant uptake of LDCTs in intervention regions 
compared to a control region. This study provides preliminary evidence that implementing 
population approaches may be a viable method to disseminate new guidelines. Our study adds to 
existing literature on best practices and effectiveness of educational outreach (e.g., Greenhalgh et 
al.23 and the AHRQ24) among strategies that facilitate the knowledge translation process; 25 and 
perhaps more importantly, addresses the recognized academic-community divide that often 
limits the reach and/or meaningfulness of the education provided to the community.26 
As noted in the findings from our survey of exposure and behavior, the lung cancer 
screening campaign inadvertently triggered thought processes concerning smoking cessation. 
This was a welcome unintended consequence of the campaign, and indicates that the 
participating population was aware that smoking is the primary risk factor for lung cancer. The 
finding also adds to the growing evidence base that smoking cessation interventions can be 
successfully implemented in screening settings.27,28 Evidence that patients associate smoking 
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behaviors and the need for screening is important, given that CMS lung cancer screening 
guidelines require counseling on the importance of smoking cessation as part of the national 
coverage requirement, in addition to the shared decision making activities described earlier.  
 4.2. Limitations. 
 The location of our study may limit the generalizability of the results to other regions in 
the United States. First, our demographic is predominantly white, with approximately 85% of 
Kentucky residents in 2015 classified as White alone, not Hispanic or Latino (compared to 
61.6% of the US population). The white demographic is even more prevalent in our study 
regions of Clay (92.7%), Pike (97.1%) and Rowan (94.5%) counties.29 Second, advertising 
efforts in this region were specifically targeted to the unique population of individuals that live in 
rural Appalachian regions. Persons in these areas may not be reflective of other populations in 
terms of educational or other socio-demographic characteristics (see again, Table 1) or in terms 
of their access to campaign features that may be effective in other areas. For example, while our 
focus groups did communicate interest in obtaining health information from the internet, we did 
not anticipate this would be a strong driver for our campaign given that state statistics show that 
23% of rural (and only 1.5% of urban) Kentuckians were without any internet access at the time 
of this study.30 Thus, while our TLC website may serve as a model for the type of messaging that 
may be effective within that community, web and social media marketing could be of greater 
utility within more “connected” population centers than was explored here. 
 Another challenge in examining the effects of our advertising campaign on LDCT uptake 
related to the diffusion effects of the intervention to other regions, and evidence that we obtained 
for competing marketing that cannot be controlled. Methodologically, it is impossible to 
establish causality using our design. It is always difficult to establish a true control community 
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for purposes of comparison, because one cannot assume that the community involved will 
remain static or uninfluenced by other campaigns or factors occurring in the experimental 
communities.31 Respondents to our campaign exposure assessment within our Pikeville (Control) 
region stated that they had exposure to television ads about lung cancer screening; and in our 
effort to contact marketing agents we received information from one hospital system in the 
region that it had undergone an extensive lung cancer screening campaign. Indeed, given the 
level of exposure to LDCT marketing in the region that served as our Control, the greater 
effectiveness on obtained LDCT orders in our intervention regions speaks to the success of our 
campaign. It should be noted that while we were unable to obtain information about the content 
of the external ads, recent research shows aggressive appeals can make smokers feel stigmatized 
and engender distrust.32 We suggest that our campaign, by using images and captions that 
express hope and survivorship and encouraged consultation with a physician or other clinician, 
offered a positive emotional message that was more trusted and stimulated more desired activity. 
 Measuring campaign dissemination effectiveness based on rates of LDCT orders 
presented additional challenges since the outcome measure depended on operational readiness to 
facilitate the change. Uptake of LDCT screening guidelines is likely to be affected by a host of 
systematic and administrative hurdles that delay order rates, and thus our reported rates may not 
adequately reflect the rate of screening that could be expected in later campaigns. In fact, in the 
assessment of the marketing efforts outside of our campaign, several hospital administrators 
outside of our LDCT centers commented that they haven't gotten the reimbursement “figured out 
yet” to begin screening. Nonetheless, our three hospital system partners were performing LDCT 
screenings, but differed in their maturity in operating and sustaining a lung cancer screening 
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program. Another limitation is that we did not capture LDCTs that may have resulted from our 
campaign that were performed outside of our three partnering hospital systems. 
5. Conclusion 
Lung cancer accounts for approximately 20% of the total cost of cancer care to Medicare, 
with aggregate costs of $4.2 billion spent over a five-year span of care ($1-2 billion more than 
the cost of colorectal or prostate cancer).33 Alerting to the need for early detection, these costs 
are known to increase for patients with more advanced disease at the time of initial diagnosis. 
Unfortunately, those costs are often incurred by those who can least afford it, since late-stage 
diagnosis has been associated with lower socioeconomic status.34,35 Our goal was to increase 
lung cancer screening rates by addressing the knowledge barrier about LDCT screening 
processes, benefits, and risks in a community population known for significant health disparities 
and health-risk behaviors. While we found increases in each of our target regions, further 
research is needed to ascertain the true impact of population-level interventions in the 
dissemination and implementation process of new evidence-based screening guidelines. 
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Table 1. Health Statistics of the Terminate Lung Cancer Focus Group Regions 
 Pikeville 
Region* 
Hazard 
Region* 
Morehead 
Region* 
Kentucky US 
Estimated Total Population†,‡ 138,374 123,067 118,309 4,395,295 318,857,056 
High School Graduation 
(adults age 25 or older)§,ǁ 
69.3% 63.4% 70.4% 82.0% 81.0% 
Median household income¶,‡  $28,111 $25,322 $26,210 $41,576 $53,046 
Prevalence of Smoking#,** 33.3% 33.4% 30.0% 28.0% 17.8% 
Premature death (Number of 
years of potential life lost 
prior to age 75 per 100,000 
population)††,‡‡ 
 
18,282 
 
16,569 
 
12,093 
 
7,562 
 
6,976 
Cancer Deaths (age-adjusted 
per 100,000 population)§§,‡‡ 
   All cancers 
   Lung and Bronchus 
 
 
240.8 
95.5 
 
 
251.9 
97.0 
 
 
224.4 
77.8 
 
 
212.0 
75.0 
 
 
171.2 
47.2 
*Pikeville Region includes Pike, Letcher, Floyd, Martin counties; Hazard Region includes Perry, 
Knott, Harlan, Leslie, Breathitt, Clay, Owsley counties; Morehead Region includes Rowan, 
Fleming, Lewis, Carter, Elliott, Morgan, Menifee, Bath counties. 
Data sources: †Population Division, U.S. Census Bureau, ‡http://quickfacts.census.gov, 
§,¶American Community Survey, U.S. Census Bureau, ǁNational Center for Education Statistics, 
#Behavioral Risk Factor Surveillance System, **Centers for Disease Control and Prevention: fast 
facts, ††Kentucky State Data Center - Vital Statistics, ‡‡National Cancer Institute: Surveillance, 
Epidemiology, and End Results (SEER) Program’s Stat Fact Sheets, §§Kentucky Cancer Registry 
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Table 2. Exposure and Behavior Survey Results 
General Exposure 
       Have you seen or heard any ads, messages, or postcards about lung cancer screening? 
          
Respondents 
 
Yes 
Response % Yes 
      145 
 
73 50.3 
      
          If Yes, Source: a    
   
f 
 
% 
television  
     
33 
 
45.2 
Radio  
      
18 
 
24.7 
Postcards in doctor office or health departments 
  
31 
 
42.5 
Internet  
      
4 
 
5.5 
Family or friends 
     
5 
 
6.9 
Other 
      
8 
 
10.95 
 
         If Yes, Did it make you?:a   
   
f 
 
% 
Think about quitting smoking 
    
41 
 
28 
Look for more information about quitting smoking 
  
4 
 
2.8 
Develop a plan to quit smoking 
   
7 
 
4.8 
Talk to a doctor about quit smoking 
   
23 
 
15.9 
Actually quit smoking 
    
13 
 
9 
Think about getting a low-dose CT scan for lung cancer screening 5 
 
3.4 
Actually get a low-dose CT scan for lung cancer screening 
 
5 
 
3.4 
Talk to family or other amount lung cancer screening 
 
0 
 
0 
Look for more information about screening  
  
2 
 
1.4 
 
a Presented as frequency (f) of response, as more than one response could be provided for each 
question.  
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Figure 1. Targeted population regions. Morehead, Hazard regions served as Intervention 
Regions. Pikeville served as a Control Region. 
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Figure 2. Campaign messaging and images 
  
Postcard Images:  
Radio ad content: 
“Support comes from the U-K College of Medicine and the Department of Family and Community 
Medicine, dedicated to reducing lung cancer deaths in Eastern Kentucky through the Terminate Lung 
Cancer Project. Adults ages fifty-five and older with a history of smoking or who have quit smoking 
less than 15 years ago are encouraged to talk to their doctor or health care provider about whether a 
Low-Dose C-T Scan of the chest is right for them. You can learn more online at: t-e-r-m-i-n-a-t-e-l-u-
n-g-c-a-n-c-e-r dot o-r-g.”   
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Figure 3a. C-Control Charts by Region: Intervention Regions 
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Figure 3b. C-Control Charts by Region: Control Region 
 
 
 
 
